| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10595381 | Bioorganic & Medicinal Chemistry Letters | 2013 | 4 Pages |
Abstract
A series of benzimidazole based HDAC inhibitors have been rationally designed, synthesized and screened. The SAR of this new chemotype is described. The lead compound, 11e, showed strong activity in several cellular assays and demonstrated in vivo efficacy in mouse xenograft pancreatic cancer models.
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Tong Wang, Mario Sepulveda, Paul Gonzales, Stephen Gately,